OB-GYN Grand Rounds-15259-------1/18/2013, Niswonger Children's Hospital
Sarah T. Melton, PharmD, BCPP, BCACP, CGP, FASCP
Dr. Melton reports there is NOT a financial interest/arrangement of affiliation with one or more organizations which could be perceived as a real or apparent
COI in the context of this presentation.
This Continuing Medical Education activity has not received support from any commercial source.
'Expecting the Unexpected: Treatment of Opioid Dependence in Pregnancy'
How well did this activity meet the stated learning objective?
ExcellentAbove AverageAverageBelow AveragePoor
Evaluate evidence-based literature regarding treatment of opioid dependency during pregnancy with buprenorphine or methadone          
Contrast the benefits and disadvantages associated with the use of buprenorphine or methanode in pregnant women          
Discuss the management of intrapartus and postpartum pain in opioid dependent patients          
Examine the incidence and treatment of neonatal abstinence syndrome associated with buprenorphine and methadone use in pregnancy          
Please rate this presentation:
ExcellentAbove AverageAverageBelow AveragePoor
Balanced, Objective, and Evidence Based          
Appropriate for intended audience          
Rate your level of knowledge BEFORE this educational activity          
Rate your level of knowledge AFTER this educational activity          
How well did this activity address a need you have in your practice          
Free of commercial bias    
Based on what you heard today:
Which physician attributes (core competencies) did the speaker incorporate into their presentation? Please choose all which apply:
A 31y/o woman has been stabilized on buprenorphine/naloxone for opioid depend for the pst 2 yrs, & says it 'saved her life.' She just found out she is 7wks preg. What would you recommend?
A). Stop medication immediately---B). Switch medication to buprenorphine---C). Switch medication to methadone maintenance---D). Continue buprenorphine/naloxone at current dose
Correct answer is: B        
What new information/strategy do you plan to implement into your clinical practice?
What challenges or barriers might prevent you from implementing this new information/strategy?
What topics do you feel need to be addressed in future CME activities?
If you have questions, concerns, or comments about this activity, please contact: Barbara Sucher, M.B.A., Associate Dean for CME cmeadean@etsu.edu or 423.439.8081.
Form Revised 9-2012